3 ballot items.
Three proposals will be voted on at BioAtla's Special Meeting: (1) issuance of common stock in excess of the exchange cap, (2) approval of a reverse stock split amendment to the charter, and (3) adjournment of the Special Meeting to solicit additional proxies.
Approve the issuance of common stock in excess of the Exchange Cap under the SEPA and related agreements with Yorkville and investors, enabling issuance up to the Commitment Amount and issued at prices defined by the agreements, which would dilute existing stockholders.
Approve a reverse stock split of the Common Stock at a ratio within the range of 1-for-5 to 1-for-20, at the board's discretion and without further stockholder approval, to be implemented by June 30, 2026.
Authorize adjournment of the Special Meeting to a later date to solicit additional proxies if necessary to secure votes in favor of Proposal One or Proposal Two.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ACORN CAPITAL ADVISORS, LLC | 326.29% | 5,406,345 | $865K |
| 2 | MILLENNIUM MANAGEMENT LLC | 166.37% | 2,756,674 | $444K |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 99.54% | 1,649,252 | $266K |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 74.47% | 1,233,919 | $198 |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 36.62% | 606,734 | $98K |
| 6 | DEUTSCHE BANK AG\ | 31.71% | 525,352 | $84K |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 30.81% | 510,514 | $82K |
| 8 | BlackRock, Inc. | 29.03% | 480,931 | $77K |
| 9 | CITADEL ADVISORS LLC | 25.82% | 427,858 | $69K |
| 10 | UBS Group AG | 20.29% | 336,158 | $54K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.
